Philip Demokritou

Dr. Philip Demokritou

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
GDGlen DeLoid
Glen DeLoid
JCJoel M. Cohen
Joel M. Cohen
TDTom Darrah
Tom Darrah
RDRaymond Derk
Raymond Derk
LRLiying Rojanasakul
Liying Rojanasakul
PDPhilip Demokritou
Philip Demokritou
The need for accurate in vitro dosimetry remains a major obstacle to the development of cost-effective toxicological screening methods for engineered nanomaterials. An important key to accurate in vitro dosimetry is the characterization of sedimentation and diffusion rates of nanoparticles suspended in culture media, which largely depend upon the effective density and diameter of formed agglomerates in suspension. Here we present a rapid and inexpensive method for accurately measuring the effective density of nano-agglomerates in suspension. This novel method is based on the volume of the pellet obtained by benchtop centrifugation of nanomaterial suspensions in a packed cell volume tube, and is validated against gold-standard analytical ultracentrifugation data. This simple and cost-effective method allows nanotoxicologists to correctly model nanoparticle transport, and thus attain accurate dosimetry in cell culture systems, which will greatly advance the development of reliable and efficient methods for toxicological testing and investigation of nano–bio interactions in vitro.

19 January 2017 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
GDGlen M DeLoid
Glen M DeLoid
JCJoel M Cohen
Joel M Cohen
GPGeorgios Pyrgiotakis
Georgios Pyrgiotakis
PDPhilip Demokritou
Philip Demokritou

22 July 2008 in Environmental Health
Verified
Journal Article
Open access
PDF file
NMNicos Middleton
Nicos Middleton
PYPANAYIOTIS YIALLOUROS
PANAYIOTIS YIALLOUROS
SKSavvas Kleanthous
Savvas Kleanthous
OKOurania Kolokotroni
Ourania Kolokotroni
JSJoel Schwartz
Joel Schwartz
PKPetros Koutrakis
Petros Koutrakis
To date, a substantial body of research has shown adverse health effects of short-term changes in levels of air pollution. Such associations have not been investigated in smaller size cities in the Eastern Mediterranean. A particular feature in the region is dust blown from the Sahara a few times a year resulting in extreme PM10 concentrations. It is not entirely clear whether such natural phenomena pose the same risks. The effect of changes in daily levels of particulate matter (PM10) and ozone (O3) on hospitalization for all, cardiovascular and respiratory causes in the two hospitals in Nicosia during 1 January 1995 and 30 December 2004 was investigated using generalized additive Poisson models after controlling for long- and short-term patterns as well as for the effect of weather. Meteorological records were reviewed to identify dust-storm days and analyses were repeated to quantify their effect on cardio-respiratory morbidity. For every 10 microg/m3 increase in daily average PM10 concentrations, there was a 0.9% (95%CI: 0.6%, 1.2%) increase in all-cause and 1.2% (95%CI: -0.0%, 2.4%) increase in cardiovascular admissions. With respect to respiratory causes, an effect was observed only in the warm months. No lagged effects with levels of PM10 were observed. In contrast, positive associations with levels of ozone were only observed the two days prior to admission. These appeared stronger for cardiovascular causes and independent of the effect of PM. All-cause and cardiovascular admissions were 4.8% (95%CI: 0.7%, 9.0%) and 10.4% (95%CI: -4.7%, 27.9%) higher on dust storm days respectively. In both cases the magnitude of effect was comparable to that seen on the quartile of non-storm days with the highest levels of PM10. We observed an increased risk of hospitalization at elevated levels of particulate matter and ozone generally consistent with the magnitude seen across several European cities. We also observed an increased risk of hospitalization on dust storm days, particularly for cardiovascular causes. While inference from these associations is limited due to the small number of dust storm days in the study period, it would appear imperative to issue health warnings for these natural events, particularly directed towards vulnerable population groups.

6 June 2018 in ACS Nano
Verified
Journal Article
Closed access
GDGlen DeLoid
Glen DeLoid
ISIkjot Singh Sohal
Ikjot Singh Sohal
LLLaura R. Lorente
Laura R. Lorente
RMRamon M. Molina
Ramon M. Molina
GPGeorgios Pyrgiotakis
Georgios Pyrgiotakis
PDPhilip Demokritou
Philip Demokritou

1 May 2014 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
JCJoel M Cohen
Joel M Cohen
JTJustin G Teeguarden
Justin G Teeguarden
PDPhilip Demokritou
Philip Demokritou
There is a great need for screening tools capable of rapidly assessing nanomaterial toxicity. One impediment to the development of reliable in vitro screening methods is the need for accurate measures of cellular dose. We present here a methodology that enables accurate determination of delivered to cell dose metrics. This methodology includes (1) standardization of engineered nanomaterial (ENM) suspension preparation; (2) measurement of ENM characteristics controlling delivery to cells in culture; and (3) calculation of delivered dose as a function of exposure time using the ISDD model. The approach is validated against experimentally measured doses, and simplified analytical expressions for the delivered dose (Relevant In Vitro Dose (RID)f function) are derived for 20 ENMs. These functions can be used by nanotoxicologists to accurately calculate the total mass (RIDM), surface area (RIDSA), or particle number (RIDN) delivered to cells as a function of exposure time.

20 March 2012 in Nanotoxicology
Verified
Journal Article
Closed access
PDF file
JCJoel Cohen
Joel Cohen
GDGlen DeLoid
Glen DeLoid
GPGeorgios Pyrgiotakis
Georgios Pyrgiotakis
PDPhilip Demokritou
Philip Demokritou
In vitro toxicity assays are efficient and inexpensive tools for screening the increasing number of engineered nanomaterials (ENMs) entering the consumer market. However, the data produced by in vitro studies often vary substantially among different studies and from in vivo data. In part, these discrepancies may be attributable to lack of standardisation in dispersion protocols and inadequate characterisation of particle–media interactions which may affect the particle kinetics and the dose delivered to cells. In this study, a novel approach for preparation of monodisperse, stabilised liquid suspensions is presented and coupled with a numerical model which estimates delivered dose values. Empirically derived material- and media-specific functions are presented for each media–ENM system that can be used to convert administered doses to delivered doses. The interactions of ENMs with a variety of physiologic media were investigated and the importance of this approach was demonstrated by in vitro cytotoxicity assays using THP-1 macrophages.